OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin-Reference-Cited by-同舟云学术

OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin

Published:2014-06-24 Issue:27 Volume:111 Page:9983-9988
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proc Natl Acad Sci USA

Author:

Chen Ligong,Shu Yan,Liang Xiaomin,Chen Eugene C.,Yee Sook Wah,Zur Arik A.,Li Shuanglian,Xu Lu,Keshari Kayvan R.,Lin Michael J.,Chien Huan-Chieh,Zhang Youcai,Morrissey Kari M.,Liu Jason,Ostrem Jonathan,Younger Noah S.,Kurhanewicz John,Shokat Kevan M.,Ashrafi Kaveh,Giacomini Kathleen M.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference40 articles.

1. Membrane transporters in drug development

2. Polyspecific Organic Cation Transporters: Structure, Function, Physiological Roles, and Biopharmaceutical Implications

3. Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action

4. Involvement of Organic Cation Transporter 1 in Hepatic and Intestinal Distribution of Metformin

5. Scientific Perspectives on Drug Transporters and Their Role in Drug Interactions

Cited by 195 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SLC13A3 is a major effector downstream of activated β-catenin in liver cancer pathogenesis;Nature Communications;2024-08-30

2. Serum proteomic profiling of physical activity reveals CD300LG as a novel exerkine with a potential causal link to glucose homeostasis;eLife;2024-08-27

3. Serum proteomic profiling of physical activity reveals CD300LG as a novel exerkine with a potential causal link to glucose homeostasis;eLife;2024-08-27

4. Metformin-associated lactic acidosis may be treatable with thiamine;Medical Hypotheses;2024-08

5. OCT1 (SLC22A1) transporter kinetics and regulation in primary human hepatocyte 3D spheroids;Scientific Reports;2024-07-27